Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
To compare the efficacy and safety of IV tigecycline to IV levofloxacin in the treatment of
 subjects with CAP requiring hospitalization.
Inclusion Criteria:

 -  Male and female subjects ≥ 18 years of age and in Bulgaria only ≤ 70 years of age

 -  Subjects hospitalized with CAP with a severity that requires IV antibiotic treatment
 for at least 7 days

 -  The presence of fever (within 24 hours before randomization)

 Exclusion Criteria:

 -  Any concomitant condition that, in the opinion of the investigator, would preclude an
 evaluation of a response or make it unlikely that the contemplated course of therapy
 could be completed (eg, life expectancy <30 days).

 -  Hospitalization within 14 days before the onset of symptoms.

 -  Residence in a long-term care facility or nursing home ≥14 days before the onset of
 symptoms.